Skip to main content

Pulmonary Vein (PV) Doppler Patterns

 

Pulmonary Vein (PV) Doppler Patterns – Normal and in Disease

Pulmonary vein Doppler is recorded using pulsed-wave Doppler (usually from apical 4-chamber view for right upper PV or by TEE). It reflects left atrial (LA) pressure and compliance, and is essential in diastology and mitral valve assessment.


━━━━━━━━━━━━━━━━━━


1. Normal Pulmonary Vein Doppler Pattern


Normal waveform has three components:


1️⃣ S wave (Systolic forward flow)


• Occurs during LV systole

• Blood flows from pulmonary veins → LA

• Normally S ≥ D in younger adults

• Reflects LA relaxation and descent of mitral annulus


2️⃣ D wave (Diastolic forward flow)


• Occurs during early LV diastole

• Corresponds to mitral E wave

• Reflects LA pressure and LV relaxation


3️⃣ Ar wave (Atrial reversal)


• Occurs during atrial contraction

• Small retrograde flow into pulmonary veins

• Normally:


Ar velocity < 35 cm/s


Ar duration < mitral A duration



πŸ‘‰ Normal Pattern: S wave dominant or equal to D

Small Ar reversal


━━━━━━━━━━━━━━━━━━


2. PV Doppler in Diastolic Dysfunction


Grade I (Impaired Relaxation)


• S wave > D wave (more systolic dominance)

• Normal or mildly increased Ar


Mechanism: Delayed LV relaxation, low early filling.



---


Grade II (Pseudonormal)


• S wave < D wave

• Increased Ar velocity

• Ar duration > mitral A duration


Mechanism: Elevated LA pressure.


πŸ‘‰ Clue: PV Doppler helps unmask pseudonormal mitral inflow.



---


Grade III/IV (Restrictive Filling)


• Markedly dominant D wave

• Blunted S wave

• Prominent Ar reversal


Mechanism: Severely elevated LA pressure and reduced compliance.


━━━━━━━━━━━━━━━━━━


3. Pulmonary Vein Doppler in Mitral Regurgitation (MR)


Mild MR


• Reduced S wave amplitude


Moderate MR


• Blunted S wave (S < D)


Severe MR


• Systolic flow reversal (retrograde flow in systole)

• Highly specific for severe MR


Mechanism: Regurgitant jet increases LA pressure in systole → reverses PV flow.


━━━━━━━━━━━━━━━━━━


4. Pulmonary Vein Doppler in Atrial Fibrillation


• No Ar wave (no organized atrial contraction)

• Variable S and D waves

• May show reduced systolic dominance


Important in estimating filling pressures.


━━━━━━━━━━━━━━━━━━


5. Constrictive Pericarditis


• Prominent respiratory variation in PV flow

• Marked decrease in D wave during inspiration


Helps differentiate from restrictive cardiomyopathy.


━━━━━━━━━━━━━━━━━━


6. Left Atrial Hypertension


Seen in: • Advanced diastolic dysfunction

• Severe MR

• LV systolic dysfunction


Pattern: • D wave dominance

• Increased Ar velocity

• Prolonged Ar duration


━━━━━━━━━━━━━━━━━━


Quick Summary Table


Normal

S ≥ D, small Ar


Impaired relaxation

S > D


Pseudonormal

S < D, ↑ Ar


Restrictive

D >>> S, prominent Ar


Severe MR

Systolic flow reversal


AF

No Ar wave


━━━━━━━━━━━━━━━━━━

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...